期刊
METABOLITES
卷 9, 期 5, 页码 -出版社
MDPI
DOI: 10.3390/metabo9050102
关键词
breast cancer; omics; analytical platforms; chemometric methods
资金
- FCT-Fundacao para a Ciencia e a Tecnologia [PEst-OE/QUI/UI0674/2019, INNOINDIGO/0001/2015]
- FCT-Fundacao para a Ciencia e a Tecnologia (CQM)
- FCT-Fundacao para a Ciencia e a Tecnologia (Portuguese Government funds)
- Madeira 14-20 Program (project PROEQUIPRAM - Reforco do Investimento em Equipamentos e Infraestruturas Cientificas na RAM) [M1420-01-0145-FEDER-000008]
- ARDITI-Agencia Regional para o Desenvolvimento da Investigacao Tecnologia e Inovacao through Centro de Quimica da Madeira - CQM + (Madeira 14-20) [M1420-01-0145-FEDER-000005]
Cancer is a major health issue worldwide for many years and has been increasing significantly. Among the different types of cancer, breast cancer (BC) remains the leading cause of cancer-related deaths in women being a disease caused by a combination of genetic and environmental factors. Nowadays, the available diagnostic tools have aided in the early detection of BC leading to the improvement of survival rates. However, better detection tools for diagnosis and disease monitoring are still required. In this sense, metabolomic NMR, LC-MS and GC-MS-based approaches have gained attention in this field constituting powerful tools for the identification of potential biomarkers in a variety of clinical fields. In this review we will present the current analytical platforms and their applications to identify metabolites with potential for BC biomarkers based on the main advantages and advances in metabolomics research. Additionally, chemometric methods used in metabolomics will be highlighted.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据